Ofatumumab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

March 31, 2015

Study Completion Date

October 15, 2020

Conditions
Lymphoma
Interventions
BIOLOGICAL

ofatumumab

Given IV

Trial Locations (48)

10021

New York Weill Cornell Cancer Center at Cornell University, New York

11030

Don Monti Comprehensive Cancer Center at North Shore University Hospital, Manhasset

11040

Long Island Jewish Medical Center, New Hyde Park

11042

Monter Cancer Center of the North Shore-LIJ Health System, Lake Success

13210

SUNY Upstate Medical University Hospital, Syracuse

19713

CCOP - Christiana Care Health Services, Newark

19958

Tunnell Cancer Center at Beebe Medical Center, Lewes

21921

Union Hospital of Cecil County, Elkton

28501

Kinston Medical Specialists, Kinston

33331

Cleveland Clinic Florida - Weston, Weston

49017

Battle Creek Health System Cancer Care Center, Battle Creek

49307

Mecosta County Medical Center, Big Rapids

49444

Mercy General Health Partners, Muskegon

49503

Butterworth Hospital at Spectrum Health, Grand Rapids

CCOP - Grand Rapids, Grand Rapids

Lacks Cancer Center at Saint Mary's Health Care, Grand Rapids

49677

Spectrum Health Reed City Hospital, Reed City

49684

Munson Medical Center, Traverse City

52402

Iowa Blood and Cancer Care, Cedar Rapids

61350

Community Hospital of Ottawa, Ottawa

Oncology Hematology Associates of Central Illinois, PC - Ottawa, Ottawa

61354

Illinois CancerCare - Peru, Peru

Illinois Valley Community Hospital, Peru

61362

Illinois CancerCare - Spring Valley, Spring Valley

61401

Galesburg Clinic, PC, Galesburg

61455

Illinois CancerCare - Macomb, Macomb

61520

Illinois CancerCare - Canton, Canton

61530

Eureka Community Hospital, Eureka

Illinois CancerCare - Eureka, Eureka

61554

Cancer Treatment Center at Pekin Hospital, Pekin

61603

Illinois CancerCare - Pekin, Pekin

61614

Proctor Hospital, Peoria

61615

CCOP - Illinois Oncology Research Association, Peoria

Oncology Hematology Associates of Central Illinois, PC - Peoria, Peoria

61636

Methodist Medical Center of Illinois, Peoria

61701

Illinois CancerCare - Bloomington, Bloomington

61761

BroMenn Regional Medical Center, Normal

Community Cancer Center, Normal

Illinois CancerCare - Community Cancer Center, Normal

63110

Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, St Louis

03301

New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care, Concord

03106

New Hampshire Oncology - Hematology, PA - Hooksett, Hooksett

03246

Lakes Region General Hospital, Laconia

08043

Cancer Institute of New Jersey at Cooper - Voorhees, Voorhees Township

10549-3417

Mount Kisco Medical Group, PC, Mount Kisco

27157-1096

Wake Forest University Comprehensive Cancer Center, Winston-Salem

43210-1240

Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center, Columbus

23298-0037

Virginia Commonwealth University Massey Cancer Center, Richmond

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT01190449 - Ofatumumab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma | Biotech Hunter | Biotech Hunter